查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375922

多組學市場規模、佔有率和趨勢分析報告：按產品/服務、類型、平台、最終用途、地區和細分趨勢，2023-2030

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

多組學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球多組學市場規模將達到63.8億美元，2023年至2030年年複合成長率為15.3%。

組學技術成本下降以及私人和公共機構投資和資金籌措增加等因素預計將推動市場發展。由於製藥公司、生技公司和學術研究機構的需求不斷增加，市場競爭日益激烈，預計也將在預測期內推動市場成長。

隨著技術的進步，組學技術的成本預計會降低，使研究人員更容易獲得資料，從而推動市場成長。公司正在專注於技術進步以降低成本。例如，Amazon Web Services 於 2022 年 11 月宣布推出 Amazon Omics Services。該服務利用生物資訊學友善的儲存選項來儲存原始序列資料並降低成本。因此，較低的成本預計將使研究人員和臨床醫生更容易獲得組學技術。這種成本的降低預計將增加多組學方法的採用。

私人和公共參與者增加的投資和資金預計將增加對多組學產品和服務的需求。多家公司正大力投資開發多組學平台和技術。例如，2022年1月，羅氏向生技公司Freenome投資2.9億美元。該投資用於加速該公司用於早期癌症檢測的多組學平台。此外，2023 年 5 月，MultiOmic Health 完成了 620 萬美元的資金籌措，用於建立精準治療藥物發現平台。因此，由於資金籌措和投資的增加，新興市場預計將開發各種新平台和產品。

市場相關人員日益關注開發創新產品和服務也是推動市場需求成長的關鍵因素。為了應對日益激烈的競爭，各公司正在開發新穎的平台。例如，2023 年 2 月，Via Scientific, Inc. 宣布推出 Foundry，這是一個多組學加速器平台，支援多組學研究期間複雜資料和分析任務的自動化。預計此類產品的推出將在預測期內推動該行業的發展。

多組學市場報告亮點

  • 按產品/服務分類，產品領域在市場中佔據主導地位，2022年銷售佔有率將達到60.5%，這是由於設備和軟體等產品的推出不斷增加。
  • 按類型分類，批量多組學是業界最大的收益貢獻者。另一方面，由於對單細胞多組學理解複雜生物系統的需求不斷增加，單細胞多組學預計在預測期內將以 17.8% 的年複合成長率成長最快。
  • 按平台分類，基因組學佔據市場主導地位，2022 年銷售額佔有率為 40.6%。這種成長是由於該細分市場提供了大量產品。
  • 從應用來看，細胞生物學領域到2022年將佔據38.8%的佔有率，佔據全球產業主導地位。相反，預計腫瘤學領域在預測期內將達到最高成長率。
  • 按最終用途分類，學術和研究機構部門是業界最大的收益貢獻者，佔有率為 50.7%。相較之下，由於對多組學加速藥物研發發現和開發的需求不斷增加，製藥和生物技術公司預計將成長最快。
  • 由於該地區主要市場參與者的存在，北美在 2022 年以 48.45% 的收益佔有率主導全球產業。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
  • 產業分析工具

第4章 產品和服務的業務分析

  • 多組學市場：產品與服務變化分析
  • 產品
    • 產品市場，2018-2030
    • 樂器
    • 消耗品
    • 軟體
  • 服務
    • 服務市場，2018-2030

第5章 業務分析類型

  • 多組學市場：類型變異分析
  • 單細胞多組學
  • 批量多組學

第6章 平台業務分析

  • 多組學市場：平台波動分析
  • 基因組學
    • 基因組學市場，2018-2030
  • 轉錄組學
    • 轉錄組學市場，2018-2030
  • 蛋白質體學
    • 蛋白質體學市場，2018-2030
  • 代謝組學
    • 代謝組學市場，2018-2030
  • 整合組學平台
    • 整合組學平台市場，2018-2030

第7章 應用業務分析

  • 多組學市場：應用變化分析
  • 細胞生物學
  • 腫瘤學
  • 神經病學
  • 免疫學

第8章 最終用途業務分析

  • 多組學市場：最終用途變異分析
  • 學術研究所
    • 學術研究機構市場，2018-2030
  • 製藥和生物技術公司
    • 製藥和生物技術公司市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第9章 區域業務分析

  • 2022 年和 2030 年按地區分類的多組學市場佔有率
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年企業市場分析
  • 公司簡介/名單
    • BD
    • Thermo Fisher Scientific, Inc,
    • Illumina
    • Danaher
    • PerkinElmer
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies
    • BGI
Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

  • Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2022, which can be attributed to the rising launches of products such as instruments and software
  • Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.6% in 2022. The growth is attributed to the high number of products available in this segment
  • Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2022. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
  • Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2022 with a revenue share of 48.45%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Platform & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Platform & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for single cell omics
      • 3.2.1.2. Advancements in omics technology and decreasing costs of omics technologies
      • 3.2.1.3. Increasing investments and funding from private and public players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges in multiomics data integration and data complexity
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Multiomics Market: Product & Service Movement Analysis
  • 4.2. Products
    • 4.2.1. Products Market, 2018 - 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.2.4. Software
      • 4.2.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.3. Services
    • 4.3.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis

  • 5.1. Multiomics Market: Type Movement Analysis
  • 5.2. Single- Cell Multiomics
    • 5.2.1. Single- Cell Multiomics Market, 2018 - 2030 (USD Million)
  • 5.3. Bulk Multiomics
    • 5.3.1. Bulk Multiomics Market, 2018 - 2030 (USD Million)

Chapter 6. Platform Business Analysis

  • 6.1. Multiomics Market: Platform Movement Analysis
  • 6.2. Genomics
    • 6.2.1. Genomics Market, 2018 - 2030 (USD Million)
  • 6.3. Transcriptomics
    • 6.3.1. Transcriptomics Market, 2018 - 2030 (USD Million)
  • 6.4. Proteomics
    • 6.4.1. Proteomics Market, 2018 - 2030 (USD Million)
  • 6.5. Metabolomics
    • 6.5.1. Metabolomics Market, 2018 - 2030 (USD Million)
  • 6.6. Integrated Omics Platforms
    • 6.6.1. Integrated Omics Platforms Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Multiomics Market: Application Movement Analysis
  • 7.2. Cell Biology
    • 7.2.1. Cell Biology Market, 2018 - 2030 (USD Million)
  • 7.3. Oncology
    • 7.3.1. Oncology Market, 2018 - 2030 (USD Million)
  • 7.4. Neurology
    • 7.4.1. Neurology Market, 2018 - 2030 (USD Million)
  • 7.5. Immunology
    • 7.5.1. Immunology Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Multiomics Market: End-use Movement Analysis
  • 8.2. Academic and Research Institutes
    • 8.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.4. Others
    • 8.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Multiomics Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. North America Multiomics Market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. U.S. Multiomics Market, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Canada Multiomics Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. UK Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Germany Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. France Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Italy Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Spain Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Denmark Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Sweden Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Norway Multiomics Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Japan Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. China Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. India Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Australia Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Thailand Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. South Korea Multiomics Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Brazil Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Mexico Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Argentina Multiomics Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. South Africa Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Saudi Arabia Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. UAE Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Kuwait Multiomics Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2022
  • 10.4. Company Profiles/Listing
    • 10.4.1. BD
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc,
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Illumina
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PerkinElmer
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Shimadzu Corporation
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Bruker
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Agilent Technologies
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 4 Global Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 6 Global Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 Global Multiomics Market, By Region, 2018 - 2030 (USD Million)
  • Table 9 North America Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 11 North America Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 North America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 13 North America Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 North America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 16 U.S. Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 18 U.S. Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 Canada Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 21 Canada Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 23 Canada Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Canada Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 Europe Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 27 Europe Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Europe Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 29 Europe Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 UK Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 32 UK Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 UK Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 34 UK Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 UK Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Germany Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 37 Germany Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Germany Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 39 Germany Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 Germany Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 France Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 42 France Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 France Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 44 France Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 France Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 46 Spain Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 47 Spain Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Spain Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 49 Spain Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Spain Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51 Italy Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 52 Italy Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 54 Italy Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Italy Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 56 Denmark Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 57 Denmark Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Denmark Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 59 Denmark Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 Denmark Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Norway Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 62 Norway Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Norway Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 64 Norway Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Norway Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Sweden Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 69 Sweden Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Sweden Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 China Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 78 China Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 China Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 80 China Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 81 China Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82 Japan Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Japan Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Japan Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 85 Japan Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Japan Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 India Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 88 India Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 India Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 90 India Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 91 India Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 92 South Korea Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 93 South Korea Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 South Korea Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 95 South Korea Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 South Korea Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 97 Australia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 98 Australia Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 99 Australia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 100 Australia Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Australia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 102 Thailand Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 103 Thailand Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 105 Thailand Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 107 Latin America Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 109 Latin America Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Latin America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 111 Latin America Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 113 Brazil Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 114 Brazil Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 Brazil Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 116 Brazil Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 118 Mexico Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 119 Mexico Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 120 Mexico Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 121 Mexico Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
  • Table 124 Argentina Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 126 Argentina Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 128 MEA Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 129 MEA Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 130 MEA Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 131 MEA Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 132 MEA Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 133 MEA Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 135 South Africa Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 137 South Africa Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 138 South Africa Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 139 UAE Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 140 UAE Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 141 UAE Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 142 UAE Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 143 UAE Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
  • Table 145 Saudi Arabia Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 146 Saudi Arabia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 147 Saudi Arabia Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 148 Saudi Arabia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Multiomics Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Multiomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global multiomics market: Product & Service outlook and key takeaways
  • Fig. 15 Global multiomics market: Product & Service movement analysis
  • Fig. 16 Global multiomics market, for products, 2018 - 2030 (USD Million)
  • Fig. 17 Global multiomics market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global multiomics market, for consumables, 2018 - 2030 (USD Million)
  • Fig. 19 Global multiomics market, for software, 2018 - 2030 (USD Million)
  • Fig. 20 Global multiomics market, for services, 2018 - 2030 (USD Million)
  • Fig. 21 Global multiomics market: Type outlook and key takeaways
  • Fig. 22 Global multiomics market: Type movement analysis
  • Fig. 23 Global multiomics market, for single- cell multiomics, 2018 - 2030 (USD Million)
  • Fig. 24 Global multiomics market, for bulk multiomics, 2018 - 2030 (USD Million)
  • Fig. 25 Global multiomics market: Platform outlook and key takeaways
  • Fig. 26 Global multiomics market: Platform movement analysis
  • Fig. 27 Global multiomics market, for genomics, 2018 - 2030 (USD Million)
  • Fig. 28 Global multiomics market, for transcriptomics, 2018 - 2030 (USD Million)
  • Fig. 29 Global multiomics market, for proteomics, 2018 - 2030 (USD Million)
  • Fig. 30 Global multiomics market, for metabolomics, 2018 - 2030 (USD Million)
  • Fig. 31 Global multiomics market, for integrated omics platforms, 2018 - 2030 (USD Million)
  • Fig. 32 Global multiomics market: Application outlook and key takeaways
  • Fig. 33 Global multiomics market: Application movement analysis
  • Fig. 34 Global multiomics market, for cell biology, 2018 - 2030 (USD Million)
  • Fig. 35 Global multiomics market, for oncology, 2018 - 2030 (USD Million)
  • Fig. 36 Global multiomics market, for neurology, 2018 - 2030 (USD Million)
  • Fig. 37 Global multiomics market, for immunology, 2018 - 2030 (USD Million)
  • Fig. 38 Global multiomics market: End-use outlook and key takeaways
  • Fig. 39 Global multiomics market: End-use movement analysis
  • Fig. 40 Global multiomics market, for academic and research institutes, 2018 - 2030 (USD Million)
  • Fig. 41 Global multiomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 42 Global multiomics market, for others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 Regional outlook, 2022 & 2030
  • Fig. 45 Global multiomics market: Region movement analysis
  • Fig. 46 North America multiomics market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. multiomics market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada multiomics market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe multiomics market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany multiomics market, 2018 - 2030 (USD Million)
  • Fig. 51 UK multiomics market, 2018 - 2030 (USD Million)
  • Fig. 52 France multiomics market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy multiomics market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain multiomics market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark multiomics market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden multiomics market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway multiomics market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific multiomics market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan multiomics market, 2018 - 2030 (USD Million)
  • Fig. 60 China multiomics market, 2018 - 2030 (USD Million)
  • Fig. 61 India multiomics market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia multiomics market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea multiomics market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand multiomics market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America multiomics market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil multiomics market, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico multiomics market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina multiomics market, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa multiomics market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa multiomics market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia multiomics market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE multiomics market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait multiomics market, 2018 - 2030 (USD Million)